Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group

Florette K. Hazard, Angus M.S. Toland, Serena Y. Tan, Bill Chiu, Naohiko Ikegaki, Arlene Naranjo, Susan L. Cohn, Wendy B. London, Julie M. Gastier-Foster, Nilsa C. Ramirez, Shalini C. Reshmi, Elizabeth Wagner, Jed Nuchtern, Shahab Asgharzadeh, Araz Marachelian, John M. Maris, Rochelle Bagatell, Julie R. Park, Meredith S. Irwin, Michael D. Hogarty, Hiroyuki Shimada

Open source

DOI: 10.1158/1078-0432.ccr-24-4369
Published: 2025-10-27
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-24-4369,
  title = {Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group},
  author = {Florette K. Hazard and Angus M.S. Toland and Serena Y. Tan and Bill Chiu and Naohiko Ikegaki and Arlene Naranjo and Susan L. Cohn and Wendy B. London and Julie M. Gastier-Foster and Nilsa C. Ramirez and Shalini C. Reshmi and Elizabeth Wagner and Jed Nuchtern and Shahab Asgharzadeh and Araz Marachelian and John M. Maris and Rochelle Bagatell and Julie R. Park and Meredith S. Irwin and Michael D. Hogarty and Hiroyuki Shimada},
  year = {2025},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-24-4369},
  url = {https://doi.org/10.1158/1078-0432.ccr-24-4369}
}

RIS

TY  - JOUR
TI  - Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group
AU  - Florette K. Hazard
AU  - Angus M.S. Toland
AU  - Serena Y. Tan
AU  - Bill Chiu
AU  - Naohiko Ikegaki
AU  - Arlene Naranjo
AU  - Susan L. Cohn
AU  - Wendy B. London
AU  - Julie M. Gastier-Foster
AU  - Nilsa C. Ramirez
AU  - Shalini C. Reshmi
AU  - Elizabeth Wagner
AU  - Jed Nuchtern
AU  - Shahab Asgharzadeh
AU  - Araz Marachelian
AU  - John M. Maris
AU  - Rochelle Bagatell
AU  - Julie R. Park
AU  - Meredith S. Irwin
AU  - Michael D. Hogarty
AU  - Hiroyuki Shimada
PY  - 2025
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-24-4369
UR  - https://doi.org/10.1158/1078-0432.ccr-24-4369
ER  -

APA

Hazard, F. K., Toland, A. M., Tan, S. Y., Chiu, B., Ikegaki, N., Naranjo, A., Cohn, S. L., London, W. B., Gastier-Foster, J. M., Ramirez, N. C., Reshmi, S. C., Wagner, E., Nuchtern, J., Asgharzadeh, S., Marachelian, A., Maris, J. M., Bagatell, R., Park, J. R., Irwin, M. S., Hogarty, M. D., & Shimada, H. (2025). Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children’s Oncology Group. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-24-4369

Source records

crossref · retrieved 2026-09-26T21:26:01.610Z